BioRestorative Therapies Balance Sheet Health
Financial Health criteria checks 6/6
BioRestorative Therapies has a total shareholder equity of $10.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $16.1M and $5.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$14.68m |
| Equity | US$10.80m |
| Total liabilities | US$5.32m |
| Total assets | US$16.12m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: BRTX's short term assets ($15.0M) exceed its short term liabilities ($5.3M).
Long Term Liabilities: BRTX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BRTX is debt free.
Reducing Debt: BRTX currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BRTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BRTX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 5.4% each year.